BMI OrganBank
BMI OrganBank is a pioneering medical device company dedicated to developing advanced organ and tissue preservation and reconditioning solutions. With research facilities in Winston-Salem, NC, and Research Triangle Park, NC, the company focuses on innovative perfusion systems, pharmacodynamic research platforms, and tissue preservation technologies. Their mission is to transform transplantation, reduce waitlists, and improve patient outcomes through cutting-edge research, proprietary technologies, and strategic partnerships. BMI collaborates with academic institutions, government agencies, and industry leaders to bring novel solutions to market, including organ transport systems, preservation platforms, and regenerative medicine tools.
Industries
Nr. of Employees
small (1-50)
BMI OrganBank
391 Technology Way, Winston-Salem, NC 27101, USA
Products
Transport-optimized organ perfusion unit
A portable perfusion unit designed to provide active, temperature-controlled perfusion for donor organs during extended ground and air transport.
Centralized multi-unit docking and reconditioning system
A facility-integrated docking system that connects multiple perfusion units to enable centralized extended preservation, simultaneous organ management, and active reconditioning workflows.
Mobile organ monitoring and decision-support application
A mobile telemetry application providing real-time tracking, live parameter monitoring, alerts, and integration with predictive models to support operational and clinical decision-making during transport and storage.
Acellular perfusate formulation for organ perfusion
A formulated acellular perfusate intended to reproduce key plasma physicochemical properties for use in organ perfusion experiments, extended preservation, and device compatibility testing.
Transport-optimized organ perfusion unit
A portable perfusion unit designed to provide active, temperature-controlled perfusion for donor organs during extended ground and air transport.
Centralized multi-unit docking and reconditioning system
A facility-integrated docking system that connects multiple perfusion units to enable centralized extended preservation, simultaneous organ management, and active reconditioning workflows.
Mobile organ monitoring and decision-support application
A mobile telemetry application providing real-time tracking, live parameter monitoring, alerts, and integration with predictive models to support operational and clinical decision-making during transport and storage.
Acellular perfusate formulation for organ perfusion
A formulated acellular perfusate intended to reproduce key plasma physicochemical properties for use in organ perfusion experiments, extended preservation, and device compatibility testing.
Services
Contract research using perfusion platforms to design and run translational preclinical and ex vivo studies, perform PK/PD testing, and generate data for device and therapeutic evaluation.
Laboratory services including histopathology, cellular and molecular imaging, flow/mass cytometry, multiplex biomarker assays, targeted genomic quantitation, and LC-MS/MS analysis to support translational studies.
Contract research using perfusion platforms to design and run translational preclinical and ex vivo studies, perform PK/PD testing, and generate data for device and therapeutic evaluation.
Laboratory services including histopathology, cellular and molecular imaging, flow/mass cytometry, multiplex biomarker assays, targeted genomic quantitation, and LC-MS/MS analysis to support translational studies.
Expertise Areas
- Organ preservation and ex vivo perfusion platform development
- Translational ex vivo pharmacodynamic and PK/PD research
- Preclinical large-animal modeling and human ex vivo tissue studies
- Analytical biomarker assays and integrated translational analytics
Key Technologies
- Normothermic and oxygenated ex vivo perfusion
- Cardiovascular-emulating perfusion platforms
- Portable perfusion transport hardware
- Multi-unit docking and centralized perfusion infrastructure
News & Updates
Partnership to develop and launch organ preservation and reconditioning technology, focusing initially on kidney transplantation.
Funded by NSF, supporting regenerative medicine programs.
Partnership involving Wake Forest Institute for Regenerative Medicine and BMI OrganBank.
Development of novel organ preservation systems to reduce the transplant waitlist.
Collaboration to develop limb preservation technology.
Research on kidney gene therapy supported by BMI technology.
Partnership to develop and launch organ preservation and reconditioning technology, focusing initially on kidney transplantation.
Funded by NSF, supporting regenerative medicine programs.
Partnership involving Wake Forest Institute for Regenerative Medicine and BMI OrganBank.
Development of novel organ preservation systems to reduce the transplant waitlist.
Collaboration to develop limb preservation technology.
Research on kidney gene therapy supported by BMI technology.